[Federal Register Volume 68, Number 211 (Friday, October 31, 2003)]
[Notices]
[Page 62092]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-27403]



[[Page 62092]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552(b)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel, Clinical Trials Unit.
    Date: November 25, 2003.
    Time: 9 a.m. to 11 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Boulevard, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Maxine A. Lesniak, MPH, Scientific Review 
Administrator, Review Branch, DEA, NIDDK, National Institutes of 
Health, Room 756, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 
(301) 594-7792, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel, Pathophysiology of Renal 
Allograft Dysfunction.
    Date: December 8, 2003.
    Time: 11 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Boulevard, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Maxine A. Lesniak, MPH, Scientific Review 
Administrator, Review Branch, DEA, NIDDK, National Institutes of 
Health, Room 756, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 
(301) 594-7792, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel, Immune Pathogenesis in 
Murine and Human T1D (Type 1 Diabetes).
    Date: December 12, 2003.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Maxine A. Lesniak, MPH, Scientific Review 
Administrator, Review Branch, DEA, NIDDK, National Institutes of 
Health, Room 756, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 
(301) 594-7792, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: October 24, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-27403 Filed 10-30-03; 8:45 am]
BILLING CODE 4140-01-M